Brazilian ant farm yields new antifungal compound by Brooks Hays Washington DC (UPI) Jan 20, 2021 Scientists have discovered a unique metabolite molecule utilized by a diversity of attine ants, or fungus-farming ants, in Brazil. The the new molecule, attinimicin, described Wednesday in the journal ACS Central Science, is structurally too complex to serve as a useful drug model. Scientists say they are hopeful, however, that ongoing surveys of attine ant farms will eventually reveal medically useful compounds. "We've discovered several antifungal metabolites, like selvamicin, that have garnered significant interest, however it is an uphill climb to get anything into the clinic," study co-author Eric Helfrich, researcher at Harvard Medical School, told UPI in an email. Fungus-farming ants are one of many groups of organisms, including beetles, termites, sponges and squid, that use symbiotic relationships with microbes to chemically defend themselves. Attine ants don't use microbial communities to protect themselves, exactly -- they rely on them to protect their crops. "The main role of the bacteria in the ant system is to protect the cultivar, food fungus, from getting contaminated by the pathogenic fungus," Helfrich said. Fungus-farming ants throughout the Americas have been found to utilize similar combinations of bacteria strains. However, scientists have been flummoxed by the structural diversity of metabolites produced by attine ant bacteria. "Over the years we have learned that the machinery that encodes the production of these small molecules can easily be swapped -- horizontal gene transfer -- so bacteria can easily test out a new metabolite," Helfrich said. "It appears that the bacteria that live on the ants are very good at testing out their neighbors' small molecules and this is the main driver of the observed diversity among the small molecules they produce," "Horizontal gene transfer is much quicker than having the bacterium evolve a new molecule from scratch," he said. "That is what makes the attinimicin story so unique and really tells us that attinimicin has an important ecological role in this system." The discovery of attinimicin marks the first time scientists have identified a metabolite molecule shared by distinct, geographically disparate groups of attine ants. In lab tests, researchers found attinimicin provided antifungal activity, protecting food fungus from fungal parasites. However, unlike antibiotics, attinimicin was only able to offer its protective qualities in the absence of iron. Attinimicin also worked to rid mouse models of a Candida albicans infection. Inspired by the discovery of the broadly distributed metabolite, researchers plan to continue probing attine ant colonies and their fungus farms for medically relevant compounds.
Canadian researchers create new form of cultivated meat Hamilton, Canada (SPX) Jan 20, 2021 McMaster researchers have developed a new form of cultivated meat using a method that promises more natural flavour and texture than other alternatives to traditional meat from animals. Researchers Ravi Selvaganapathy and Alireza Shahin-Shamsabadi, both of the university's School of Biomedical Engineering, have devised a way to make meat by stacking thin sheets of cultivated muscle and fat cells grown together in a lab setting. The technique is adapted from a method used to grow tissue for human t ... read more
|
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |